Does aspirin work in ITP patients? small study raises questions
NCT ID NCT04912505
First seen Jan 07, 2026 · Last updated Apr 25, 2026 · Updated 19 times
Summary
This study tested whether a daily low-dose aspirin (75 mg) provides enough protection against blood clots in people with immune thrombocytopenia (ITP) and heart disease. ITP causes low platelet counts, and the body may break down aspirin faster than normal. The study measured platelet function 24 hours after aspirin intake in 4 adults. Results help understand if standard aspirin dosing is adequate for this group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PURPURA, THROMBOCYTOPENIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Toulouse Hospital
Toulouse, France
Conditions
Explore the condition pages connected to this study.